Aleve
NDC Package 70262-301-50

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Aleve is do not take more than directedthe smallest effective dose should be useddrink a full glass of water with each doseAdults and children 12 years and oldertake 1 caplet every 8 to 12 hours while symptoms lastfor the first dose you may take 2 caplets within the first hourdo not exceed 2 caplets in any 8- to 12-hour perioddo not exceed 3 caplets in a 24-hour periodChildren under 12 yearsask a doctor. Marketed by Your Safety Company, this product is identified by NDC 70262-301 and is authorized under FDA application NDA020204.

Identification & Billing

NDC Package Code
70262-301-50
Package Description
50 POUCH in 1 BOX / 1 TABLET in 1 POUCH
Product Code
70262-301
11-Digit Billing Format
70262030150
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Aleve Caplets
Dosage Form
-
Usage Information
Do not take more than directedthe smallest effective dose should be useddrink a full glass of water with each doseAdults and children 12 years and oldertake 1 caplet every 8 to 12 hours while symptoms lastfor the first dose you may take 2 caplets within the first hourdo not exceed 2 caplets in any 8- to 12-hour perioddo not exceed 3 caplets in a 24-hour periodChildren under 12 yearsask a doctor

Regulatory & Marketing

Labeler Name
Your Safety Company
FDA Application #
NDA020204
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
03-15-2016
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70262-301-50 identifies a specific commercial package of 50 pouch in 1 box / 1 tablet in 1 pouch of Aleve Caplets, labeled by Your Safety Company. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Your Safety Company on March 15, 2016. The current certification is valid through December 31, 2017.

How is this Your Safety Company product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70262030150. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
70262-301-50
11-Digit CMS (5-4-2)
70262-0301-50

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.